Total Payments
$22,125
2024 Payments
$190.81
Companies
19
Transactions
46
Medicare Patients
2,696
Medicare Billing
$324,381
Payment Breakdown by Category
Other$20,000 (90.4%)
Food & Beverage$1,322 (6.0%)
Travel$802.47 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $20,000 | 2 | 90.4% |
| Food and Beverage | $1,322 | 42 | 6.0% |
| Travel and Lodging | $802.47 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $10,000 | 1 | $0 (2021) |
| Medtronic Vascular, Inc. | $10,000 | 1 | $0 (2020) |
| LivaNova USA, Inc. | $1,056 | 5 | $0 (2021) |
| Eisai Inc. | $204.44 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $188.27 | 5 | $0 (2021) |
| Biogen, Inc. | $165.27 | 10 | $0 (2024) |
| CSL Behring | $125.00 | 1 | $0 (2020) |
| ABBVIE INC. | $59.25 | 3 | $0 (2022) |
| EMD Serono, Inc. | $56.23 | 2 | $0 (2024) |
| Abbott Laboratories | $44.76 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $190.81 | 8 | MDD US Operations, LLC ($35.00) |
| 2023 | $122.10 | 1 | Eisai Inc. ($122.10) |
| 2022 | $103.50 | 5 | ABBVIE INC. ($44.85) |
| 2021 | $10,126 | 7 | Medtronic, Inc. ($10,000) |
| 2020 | $10,142 | 3 | Medtronic Vascular, Inc. ($10,000) |
| 2019 | $26.06 | 2 | Novartis Pharmaceuticals Corporation ($26.06) |
| 2018 | $1,206 | 8 | LivaNova USA, Inc. ($1,036) |
| 2017 | $208.21 | 12 | Biogen, Inc. ($97.93) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Diagnostic Tracer | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: AMANTADINE | ||||||
| 10/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Central Nervous System | ||||||
| 09/26/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: EPILEPSY | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.69 | General |
| 06/18/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Neurology | ||||||
| 05/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: PAIN | ||||||
| 10/27/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $122.10 | General |
| Category: Neurology | ||||||
| 07/29/2022 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: EPILEPSY | ||||||
| 06/10/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Neurology | ||||||
| 02/18/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.54 | General |
| 02/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2021 | LivaNova USA, Inc. | VNS - Sentiva (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: PRIMARY CARE | ||||||
| 09/08/2021 | Abbott Laboratories | EnSite Precision Cardiac Mapping System (Device) | Food and Beverage | In-kind items and services | $44.76 | General |
| Category: Electrophysiology | ||||||
| 08/28/2021 | Medtronic, Inc. | — | Grant | Cash or cash equivalent | $10,000.00 | General |
| 07/16/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROLOGY | ||||||
| 04/02/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2020 | Medtronic Vascular, Inc. | — | Grant | Cash or cash equivalent | $10,000.00 | General |
| 02/05/2020 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 08/02/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 545 | 778 | $214,703 | $53,816 |
| 2022 | 8 | 602 | 827 | $179,128 | $70,295 |
| 2021 | 10 | 767 | 1,106 | $227,682 | $105,663 |
| 2020 | 9 | 782 | 1,160 | $248,285 | $94,606 |
Total Patients
2,696
Total Services
3,871
Medicare Billing
$324,381
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 135 | 230 | $49,220 | $11,419 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 155 | $33,170 | $9,989 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 83 | 128 | $38,528 | $9,478 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 64 | $19,264 | $5,889 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 45 | 45 | $17,685 | $4,354 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,004 | $3,155 | 28.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 60 | 64 | $24,182 | $2,810 | 11.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $9,360 | $2,617 | 28.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 16 | 27 | $6,362 | $2,119 | 33.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $5,928 | $1,987 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 218 | $45,923 | $21,370 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 194 | 324 | $51,864 | $20,826 | 40.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 19 | 19 | $7,600 | $5,631 | 74.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $9,822 | $4,655 | 47.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $9,090 | $4,123 | 45.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 27 | $11,996 | $2,960 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 48 | 51 | $10,914 | $2,770 | 25.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 64 | 65 | $12,805 | $2,720 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 27 | $8,127 | $2,152 | 26.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 12 | 23 | $6,664 | $1,950 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $4,323 | $1,139 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 248 | 471 | $70,650 | $31,884 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 156 | 251 | $50,200 | $25,394 | 50.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 90 | 90 | $22,500 | $11,803 | 52.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 19 | 20 | $11,000 | $7,823 | 71.1% |
About Dr. Arshad Iqbal, MD
Dr. Arshad Iqbal, MD is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174564983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arshad Iqbal, MD has received a total of $22,125 in payments from pharmaceutical and medical device companies, with $190.81 received in 2024. These payments were reported across 46 transactions from 19 companies. The most common payment nature is "Grant" ($20,000).
As a Medicare-enrolled provider, Iqbal has provided services to 2,696 Medicare beneficiaries, totaling 3,871 services with total Medicare billing of $324,381. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Other Specialties Neurology
- Location Warwick, RI
- Active Since 06/10/2006
- Last Updated 08/25/2022
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1174564983
Products in Payments
- VNS Therapy (Device) $1,036
- GILENYA (Drug) $125.00
- Hizentra (Biological) $125.00
- Leqembi (Drug) $122.10
- TYSABRI (Biological) $112.00
- Fycompa (Drug) $82.34
- QULIPTA (Drug) $44.85
- EnSite Precision Cardiac Mapping System (Device) $44.76
- VALTOCO (Drug) $37.33
- Gocovri (Drug) $35.00
- NURTEC ODT (Drug) $31.66
- UBRELVY (Drug) $31.15
- SKYCLARYS (Drug) $25.19
- KESIMPTA (Drug) $23.04
- NAMZARIC (Drug) $21.37
- Austedo XR (Drug) $20.63
- VNS - Sentiva (Device) $19.98
- REXULTI (Drug) $19.67
- NEURACEQ (Drug) $17.82
- TECFIDERA (Drug) $16.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.